Drugplain

sodium sulfate, potassium sulfate, and magnesium sulfate 1.6 g/177mL

sodium sulfate, potassium sulfate, and magnesium sulfate · SOLUTION · Bionpharma Inc.,

No Recall HistoryCurrently in Shortage
Plain English

This oral solution contains a combination of mineral salts used to cleanse the bowel before medical procedures or to treat constipation. It works by drawing water into the intestines to promote bowel movements.

Key Facts

Brand Name
sodium sulfate, potassium sulfate, and magnesium sulfate
Generic Name
sodium sulfate, potassium sulfate, and magnesium sulfate
NDC Code (Product)
69452-428
Manufacturer
Bionpharma Inc.,
Strength
1.6 g/177mL
Dosage Form
SOLUTION
Route
ORAL
Marketing Status
Application #
ANDA204135
Marketing Start
04/15/2025

Recall History

No Recall History

Side Effects Reported to FDA

FDA FAERS database · These are reported events, not confirmed side effects

vomiting48 reports
nausea38 reports
abdominal pain14 reports
dizziness14 reports
drug ineffective11 reports
headache11 reports
abdominal pain upper10 reports
abdominal distension9 reports
diarrhoea9 reports
chills8 reports

Full Prescribing Information

Source: FDA Drug Label (SPL)For healthcare professionals

Indications & Usage

1 INDICATIONS & USAGE Sodium sulfate, potassium sulfate and magnesium sulfate oral solution is indicated for cleansing of the colon as a preparation for colonoscopy in adult patients. Pediatric use information is approved for Braintree Laboratories, Inc.’s SUPREP BOWEL PREP KIT (sodium sulfate, potassium sulfate, and magnesium sulfate) oral solution. However, due to Braintree Laboratories, Inc.’s marketing exclusivity rights, this drug product is not labeled with that pediatric information. Sodium sulfate, potassium sulfate and magnesium sulfate oral solution is an osmotic laxative indicated for cleansing of the colon in preparation for colonoscopy in adult patients. ( 1 )

Dosage & Administration

2 DOSAGE AND ADMINISTRATION Preparation and Administration ( 2.2 ) Must dilute in water prior to ingestion. Administration of two bottles of sodium sulfate, potassium sulfate and magnesium sulfate oral solution is required for a complete preparation for colonoscopy. One bottle is equivalent to one dose. Must consume additional water after each dose. Stop consumption of all fluids at least 2 hours before the colonoscopy. Recommended Dosage and Administration Split-Dose (two-day) regimen consists of two doses of sodium sulfate, potassium sulfate and magnesium sulfate oral solution: first dose during the evening prior to colonoscopy and second dose the next day, during the morning of colonoscopy. ( 2.1 , 2.3 ) Recommended sodium sulfate, potassium sulfate and magnesium sulfate oral solution dosage is: o Adults: Two 6-ounce doses. ( 2.3 ) For complete information on preparation before colonoscopy and administration of the dosage regimen, see full prescribing Information. ( 2.1 , 2.2 , 2.3 ) 2.1 Dosage and Administration Overview Administration of two bottles of sodium sulfate, potassium sulfate and magnesium sulfate oral solution and additional water is required for a complete preparat

Contraindications

4 CONTRAINDICATIONS Sodium sulfate, potassium sulfate and magnesium sulfate oral solution is contraindicated in the following conditions: Gastrointestinal obstruction or ileus [see Warnings and Precautions ( 5.6 )] Bowel perforation [see Warnings and Precaution ( 5.6 )] Toxic colitis or toxic megacolon Gastric retention Hypersensitivity to any of the ingredients in sodium sulfate, potassium sulfate and magnesium sulfate oral solution Gastrointestinal obstruction or ileus ( 4 , 5.6 ) Bowel perforation ( 4 , 5.6 ) Toxic colitis or toxic megacolon ( 4 ) Gastric retention ( 4 ) Hypersensitivity to any ingredient ( 4 )

Drug Interactions

7 DRUG INTERACTIONS Drugs that increase risk of fluid and electrolyte imbalance. ( 7.1 ) Pediatric use information is approved for Braintree Laboratories, Inc.’s SUPREP BOWEL PREP KIT (sodium sulfate, potassium sulfate, and magnesium sulfate) oral solution. However, due to Braintree Laboratories, Inc.’s marketing exclusivity rights, this drug product is not labeled with that pediatric information. 7.1 Drugs That May Increase Risk of Fluid and Electrolyte Abnormalities Use caution when prescribing sodium sulfate, potassium sulfate and magnesium sulfate oral solution to patients taking medications that increase the risk of fluid and electrolyte disturbances or may increase the risk of adverse events of seizure, arrhythmias, and prolonged QT in the setting of fluid and electrolyte abnormalities [see Warnings and Precautions ( 5.1 , 5.2 , 5.3 , 5.4 )] . 7.2 Potential for Reduced Drug Absorption Sodium sulfate, potassium sulfate and magnesium sulfate oral solution can reduce the absorption of other co-administered drugs [see Dosage and Administration ( 2.1 )] . Administer oral medications at least one hour before starting each dose of sodium sulfate, potassium sulfate and magnesium sulf

Adverse Reactions

6 ADVERSE REACTIONS The following important adverse reactions for bowel preparations are described elsewhere in the labeling: Serious Fluid and Serum Chemistry Abnormalities [see Warnings and Precautions ( 5.1 )] Cardiac Arrhythmias [see Warnings and Precautions ( 5.2 )] Seizures [see Warnings and Precautions ( 5.3 )] Use in Patients with Risk of Renal Injury [see Warnings and Precautions ( 5.4 )] Colonic Mucosal Ulceration and Ischemic Colitis [see Warnings and Precautions ( 5.5 )] Patients with Significant Gastrointestinal Disease [see Warnings and Precautions ( 5.6 )] Aspiration [see Warnings and Precautions ( 5.7 )] Most common adverse reactions are: Adults (>2%): overall discomfort, abdominal distention, abdominal pain, nausea, and vomiting. ( 6.1 ) To report SUSPECTED ADVERSE REACTIONS, contact Ascend Laboratories, LLC at 1-877-272-7901 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. 6.1 Clinical Studies Experience Because clinical studies are conducted under widely varying conditions, adverse reaction rates observed in the clinical studies of a drug cannot be directly compared to rates in clinical studies of another drug and may not reflect the rates observed in practice.

Frequently Asked Questions

What is sodium sulfate, potassium sulfate, and magnesium sulfate used for?

This oral solution contains a combination of mineral salts used to cleanse the bowel before medical procedures or to treat constipation. It works by drawing water into the intestines to promote bowel movements.

Is sodium sulfate, potassium sulfate, and magnesium sulfate a controlled substance?

sodium sulfate, potassium sulfate, and magnesium sulfate is not classified as a controlled substance by the DEA.

What is the generic name for sodium sulfate, potassium sulfate, and magnesium sulfate?

The generic name for sodium sulfate, potassium sulfate, and magnesium sulfate is sodium sulfate, potassium sulfate, and magnesium sulfate. There are no other listed brand versions of sodium sulfate, potassium sulfate, and magnesium sulfate.

What is the NDC code for sodium sulfate, potassium sulfate, and magnesium sulfate 1.6 g/177mL?

The NDC (National Drug Code) for sodium sulfate, potassium sulfate, and magnesium sulfate 1.6 g/177mL is 69452-428, listed by Bionpharma Inc.,.

Product NDC

69452-428

Package NDC

69452-428-62

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)